Compounds > n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine
Page last updated: 2024-09-03

n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Multiple Sclerosis

n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine has been researched along with Multiple Sclerosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bernardi, S; Bozzao, L; Carolei, A; Fieschi, C; Pantano, P; Pozzilli, C1

Other Studies

1 other study(ies) available for n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Multiple Sclerosis

ArticleYear
Sequential computed tomography and 123I-HIPDM scans in multiple sclerosis with large plaque. A case report.
    European neurology, 1987, Volume: 27, Issue:2

    Topics: Adult; Brain; Female; Humans; Iodobenzenes; Methylprednisolone; Multiple Sclerosis; Tomography, Emission-Computed; Tomography, X-Ray Computed

1987